Csps trial stroke
WebNov 8, 2024 · Lancet 2016; 388:365. Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or … WebCSPS.com (CSPS for antiplatelet Combination) evaluated the efficacy of cilostazol and either aspirin or clopidogrel versus either aspirin or clopidogrel monotherapy. 21 Patients with ischaemic stroke within the …
Csps trial stroke
Did you know?
WebMay 16, 2024 · The risk of ischemic stroke ranges from 3 to 15% in the 90 days after a minor ischemic stroke or a transient ischemic attack (TIA). 1-5 In several trials, aspirin … National Center for Biotechnology Information
Web1.4 years in the Cilostazol Stroke Prevention Study for Anti-platelet Combination (CSPS.com), a randomized controlled trial (RCT).9-11 If DAPT using cilostazol is effective when started within 1 month after stroke onset, we may be able to obtain a promising therapeutic strategy by switching the as- WebThe combination of cilostazol with aspirin or clopidogrel had a reduced incidence of ischaemic stroke recurrence and a similar risk of severe or life-threatening bleeding compared with treatment with aspirin or clopidogrel …
WebMar 8, 2024 · Cilostazol has potential strengths for use during acute stroke, including a rapid onset of action and a low risk of bleeding. 14,-, 16 Some RCTs showed similar or … WebPrevention Study for Antiplatelet Combination (CSPS) trial reported that, among 1879 Japanese patients with high-risk noncardioembolic ischemic stroke in the previous 8–180 days, adding cilostazol to single antiplatelet therapy with aspirin or clopidogrel reduced the annual incidence of recurrent ischemic stroke by half compared with monother -
WebDec 8, 2014 · Conflicts of interest: The CSPS.com will be conducted under a trial contract between the consignee, Japan Cardiovascular Research Foundation, and the consignor, Otsuka Pharmaceutical Co., Ltd. Japan Cardiovascular Research Foundation will receive funding for trial implementation and management from Otsuka Pharmaceutical Co., Ltd. …
WebResults Eighteen randomised trials comprising 11 429 participants were included in this meta-analysis. Most trials possessed low risk of bias and were of low heterogeneity. … first platt school maidenheadWebOct 21, 2010 · Similar Efficacy, Less Bleeding With Cilostazol vs Aspirin for Recurrent Stroke Prevention: CSPS 2 Published Final results of the CSPS 2 trial, presented earlier this year, show a similar efficacy ... first platesWebApr 12, 2024 · Comparison Of Effects of Motor Relearning Program (MRP) Versus Neuro Development Treatment (NDT) For Balance and Gait in Chronic Ischemic Stroke Patients: A Randomized Clinical Trial: Estimated Study Start Date : April 1, 2024: Estimated Primary Completion Date : June 1, 2024: Estimated Study Completion Date : August 31, 2024 first platt schoolWebNov 26, 2013 · Association of Timing for Starting Dual Antiplatelet Treatment With Cilostazol and Recurrent Stroke: A CSPS.com Trial Post Hoc Analysis. Neurology. 2024 Mar … first plastic toysWebFeb 17, 2024 · In the Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com) randomized trial, cDAPT used for a median of 1.4 years reduced risk for recurrent stroke more than aspirin or clopidogrel alone. firstplay dietary foods limitedWebWe designed the second Cilostazol Stroke Prevention Study (CSPS 2) to establish non-inferiority of cilostazol versus aspirin for prevention of stroke, and to compare the efficacy … firstplay dietary foods stockportWebNov 8, 2024 · The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet 1997; 349:1569. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. firstplay dietary foods companies house